Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tachykinins and airway function

V Lagente1, C Advenier

  • 1Laboratoire de Pharmacodynamie Moléculaire, INSERM U 456, Faculté de Sciences Pharmaceutique et Biologiques, Université de Rennes 1, Rennes, F-35043, France.

Pulmonary Pharmacology & Therapeutics
|April 22, 1999
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The NLRP3 inflammasome is activated by nanoparticles through ATP, ADP and adenosine.

Cell death & disease·2015
Same author

[A new fixed dose combination of fluticasone and formoterol in a pressurised metered-dose inhaler for the treatment of asthma].

Revue des maladies respiratoires·2014
Same author

Cannabinoids inhibit cholinergic contraction in human airways through prejunctional CB1 receptors.

British journal of pharmacology·2014
Same author

Lack of involvement of type 7 phosphodiesterase in an experimental model of asthma.

The European respiratory journal·2011
Same author

Phosphoramidon potentiates the endothelin-1-induced bronchopulmonary response in guinea-pigs.

Neurochemistry international·2010
Same author

Bronchopulmonary and pressor effects of big-endothelin-1 in the guinea-pig.

Neurochemistry international·2010
Same journal

Brain-Derived Neurotrophic Factor (BDNF) Signaling in Respiratory Disease: Mechanisms, Neuroimmune Crosstalk, and Therapeutic Implications.

Pulmonary pharmacology & therapeutics·2026
Same journal

PD05, a novel neutrophil elastase inhibitor, mitigates LPS-induced acute lung injury in a preclinical model.

Pulmonary pharmacology & therapeutics·2026
Same journal

The preclinical discovery and development of depemokimab for severe eosinophilic asthma.

Pulmonary pharmacology & therapeutics·2026
Same journal

TROP2 as a promising therapeutic target in lung cancer: Current clinical trial landscape and future directions.

Pulmonary pharmacology & therapeutics·2026
Same journal

Synergistic induction of apoptosis in lung cancer cells via TOP2A targeting through combined dihydroartemisinin and chrysin treatment.

Pulmonary pharmacology & therapeutics·2026
Same journal

Evodiamine protects against lung ischemia-reperfusion injury by attenuating SYK-associated TLR4/NLRP3 inflammasome activation and ferroptosis-related injury signatures.

Pulmonary pharmacology & therapeutics·2026
See all related articles